GBI Biomanufacturing News and Resources

GBI Biomanufacturing, a contract development and manufacturing organization (CDMO), has entered a partnership with Allterum Therapeutics to produce Allterum’s lead cancer therapy candidate, 4A10. The monoclonal antibody (mAb), which targets CD127, will be manufactured for Phase 1/2a clinical trials. The